VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,274,000 | -60.8% | 771,046 | -48.8% | 0.16% | -49.8% |
| Q4 2017 | $31,321,000 | +55.8% | 1,507,346 | +7.4% | 0.32% | +42.8% |
| Q3 2017 | $20,104,000 | +19.2% | 1,403,046 | +43.9% | 0.22% | +4.2% |
| Q2 2017 | $16,867,000 | +174.8% | 975,046 | +75.1% | 0.21% | +121.9% |
| Q1 2017 | $6,139,000 | -30.2% | 556,746 | -8.0% | 0.10% | -15.8% |
| Q4 2016 | $8,789,000 | +25.9% | 605,446 | +112.9% | 0.11% | +9.6% |
| Q3 2016 | $6,981,000 | +45.2% | 284,446 | +19.1% | 0.10% | +42.5% |
| Q2 2016 | $4,807,000 | +78.4% | 238,792 | +187.5% | 0.07% | -5.2% |
| Q1 2016 | $2,695,000 | +1584.4% | 83,054 | +5342.6% | 0.08% | +2466.7% |
| Q4 2015 | $160,000 | +661.9% | 1,526 | +10800.0% | 0.00% | – |
| Q3 2015 | $21,000 | -81.4% | 14 | -97.3% | 0.00% | -100.0% |
| Q2 2015 | $113,000 | -40.5% | 517 | -46.4% | 0.00% | -25.0% |
| Q1 2015 | $190,000 | -57.8% | 964 | -57.3% | 0.00% | -55.6% |
| Q4 2014 | $450,000 | +12.8% | 2,260 | +12.2% | 0.01% | +12.5% |
| Q3 2014 | $399,000 | +121.7% | 2,014 | +582.7% | 0.01% | +100.0% |
| Q2 2014 | $180,000 | +9.8% | 295 | +59.5% | 0.00% | 0.0% |
| Q1 2014 | $164,000 | -92.5% | 185 | -98.5% | 0.00% | -90.7% |
| Q4 2013 | $2,187,000 | +33.2% | 12,485 | +20.5% | 0.04% | +16.2% |
| Q3 2013 | $1,642,000 | +0.3% | 10,357 | -24.6% | 0.04% | -14.0% |
| Q2 2013 | $1,637,000 | – | 13,744 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |